Elsayed Soliman to Fibrin Fibrinogen Degradation Products
This is a "connection" page, showing publications Elsayed Soliman has written about Fibrin Fibrinogen Degradation Products.
Connection Strength
0.585
-
Young LC, Roediger MP, Grandits G, Baker J, Somboonwit C, Williams I, Lundgren JD, Neaton JD, Soliman EZ. Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected individuals. Biomark Med. 2014; 8(9):1073-83.
Score: 0.414
-
Cordova Sanchez A, Wilkinson K, Short SAP, Howard VJ, Judd SE, Goyal P, Soliman EZ, Levitan EB, Safford MM, Cushman M. Blood Biomarkers and the Risk of Coronary Disease in Atrial Fibrillation. J Am Heart Assoc. 2026 May 05; 15(9):e45735.
Score: 0.061
-
Short SAP, Hald E, Wilkinson K, Howard G, Howard V, Judd SE, Soliman EZ, Kissela B, Robinson D, Stanton R, Cushman M. Circulating biomarkers and ischemic stroke risk in adults with atrial fibrillation taking anticoagulation: the Reasons for Geographic And Racial Differences in Stroke study. J Thromb Haemost. 2025 Oct; 23(10):3148-3159.
Score: 0.058
-
O'Neal WT, Soliman EZ, Howard G, Howard VJ, Safford MM, Cushman M, Zakai NA. Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study. Atherosclerosis. 2015 Nov; 243(1):192-7.
Score: 0.029
-
Gupta M, Miller CJ, Baker JV, Lazar J, Bogner JR, Calmy A, Soliman EZ, Neaton JD. Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection. Am J Cardiol. 2013 Mar 01; 111(5):760-4.
Score: 0.024